申请人:C.F. Boehringer & Soehne GmbH
公开号:US04070373A1
公开(公告)日:1978-01-24
Novel tricyclic aminoalkyl derivatives are disclosed which are characterized by valuable pharmacological activities and namely by cardiac and circulatory activities. The tricyclic aminoalkyl derivatives are compounds of the formula: ##STR1## wherein X is an oxygen or a sulfur atom, a saturated or unsaturated, straight chain or branched alkylene group containing up to 3 carbon atoms, an oxymethylene, thiamethylene or thiaethylene group or a valency bond, R.sub.1 is hydrogen, halogen, alkyl, alkoxy or trifluoromethyl, R.sub.2 is hydrogen or hydroxyl, R.sub.3 is hydrogen or together with R.sub.2 represents a further valency bond, R.sub.4 and R.sub.5 which may be the same or different are each hydrogen or lower alkyl, A is alkylene which is substituted by an optionally acylated hydroxyl group, Y is an oxygen or sulfur atom or an optionally alkylated imino group and Z is aryl, aralkyl, cycloalkyl or cycloalkyl-alkyl which may be substituted by halogen, hydroxyl, nitro, amino, alkoxy, aralkoxy, alkyl, trifluoromethyl, alkylamino or alkylsulfonyl group, and the acid addition salts thereof with pharmacologically acceptable acids.
本发明揭示了新型三环氨基烷基衍生物,其具有有价值的药理活性,特别是心脏和循环活性。该三环氨基烷基衍生物是以下式的化合物:##STR1##其中X是氧或硫原子,饱和或不饱和的直链或支链烷基,含有最多3个碳原子,氧甲基,硫甲基或硫乙基基团或价键,R.sub.1是氢,卤素,烷基,烷氧基或三氟甲基,R.sub.2是氢或羟基,R.sub.3是氢或与R.sub.2一起表示进一步的价键,R.sub.4和R.sub.5可以相同也可以不同,均为氢或低级烷基,A是被一个可选的酰基化羟基取代的烷基,Y是氧或硫原子或一个可选的烷基化亚胺基,Z是芳基,芳基烷基,环烷基或环烷基烷基,可以被卤素,羟基,硝基,氨基,烷氧基,芳基烷氧基,烷基,三氟甲基,烷基氨基或烷基磺酰基基团取代,以及其与药理学上可接受的酸形成的酸加成盐。